| A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells K Cadwell, JY Liu, SL Brown, H Miyoshi, J Loh, JK Lennerz, C Kishi, W Kc, ... Nature 456 (7219), 259-263, 2008 | 1769 | 2008 |
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity M Cella, A Fuchs, W Vermi, F Facchetti, K Otero, JKM Lennerz, ... Nature 457 (7230), 722-725, 2009 | 1509 | 2009 |
| Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner, R Katayama, ... Cancer discovery 6 (10), 1118-1133, 2016 | 1167 | 2016 |
| COVID-19-neutralizing antibodies predict disease severity and survival WF Garcia-Beltran, EC Lam, MG Astudillo, D Yang, TE Miller, J Feldman, ... Cell 184 (2), 476-488. e11, 2021 | 717 | 2021 |
| An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background D Mitra, X Luo, A Morgan, J Wang, MP Hoang, J Lo, CR Guerrero, ... Nature 491 (7424), 449-453, 2012 | 584 | 2012 |
| Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma L Goyal, SK Saha, LY Liu, G Siravegna, I Leshchiner, LG Ahronian, ... Cancer discovery 7 (3), 252-263, 2017 | 512* | 2017 |
| MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib JK Lennerz, EL Kwak, A Ackerman, M Michael, SB Fox, K Bergethon, ... Journal of clinical oncology 29 (36), 4803-4810, 2011 | 490 | 2011 |
| Origins of lymphatic and distant metastases in human colorectal cancer K Naxerova, JG Reiter, E Brachtel, JK Lennerz, M Van De Wetering, ... Science 357 (6346), 55-60, 2017 | 451 | 2017 |
| Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for … Z Piotrowska, H Isozaki, JK Lennerz, JF Gainor, IT Lennes, VW Zhu, ... Cancer discovery 8 (12), 1529-1539, 2018 | 408 | 2018 |
| Integrated molecular characterization of testicular germ cell tumors H Shen, J Shih, DP Hollern, L Wang, R Bowlby, SK Tickoo, V Thorsson, ... Cell reports 23 (11), 3392-3406, 2018 | 395 | 2018 |
| H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway M Eberhardt, M Dux, B Namer, J Miljkovic, N Cordasic, C Will, TI Kichko, ... Nature communications 5 (1), 4381, 2014 | 379 | 2014 |
| BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications D Dias-Santagata, Q Lam, K Vernovsky, N Vena, JK Lennerz, DR Borger, ... PloS one 6 (3), e17948, 2011 | 375 | 2011 |
| Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular … JK Lennerz, V Rühle, EP Ceppa, WL Neuhuber, NW Bunnett, EF Grady, ... Journal of Comparative Neurology 507 (3), 1277-1299, 2008 | 370 | 2008 |
| Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK … N Tanaka, JJ Lin, C Li, MB Ryan, J Zhang, LA Kiedrowski, AG Michel, ... Cancer discovery 11 (8), 1913-1922, 2021 | 363 | 2021 |
| TAS-120 overcomes resistance to ATP-competitive FGFR inhibitors in patients with FGFR2 fusion–positive intrahepatic cholangiocarcinoma L Goyal, L Shi, LY Liu, F Fece de la Cruz, JK Lennerz, S Raghavan, ... Cancer discovery 9 (8), 1064-1079, 2019 | 318 | 2019 |
| The landscape of metastatic progression patterns across major human cancers J Budczies, M von Winterfeld, F Klauschen, M Bockmayr, JK Lennerz, ... Oncotarget 6 (1), 570, 2015 | 295 | 2015 |
| Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer S Yoda, JJ Lin, MS Lawrence, BJ Burke, L Friboulet, A Langenbucher, ... Cancer discovery 8 (6), 714-729, 2018 | 291 | 2018 |
| Test performance evaluation of SARS-CoV-2 serological assays JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174, 2020 | 269 | 2020 |
| Transient receptor potential cation channel, subfamily C, member 5 (TRPC5) is a cold-transducer in the peripheral nervous system K Zimmermann, JK Lennerz, A Hein, AS Link, JS Kaczmarek, M Delling, ... Proceedings of the National Academy of Sciences 108 (44), 18114-18119, 2011 | 266 | 2011 |
| Evaluation of SARS-CoV-2 serology assays reveals a range of test performance JD Whitman, J Hiatt, CT Mowery, BR Shy, R Yu, TN Yamamoto, U Rathore, ... Nature biotechnology 38 (10), 1174-1183, 2020 | 257 | 2020 |